Evidence map›Paper›PMID 26916230›Full record

ReviewInternational journal of cancer2016

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Julia M L Brotherton, Mark Jit, Patti E Gravitt, Marc Brisson, Aimée R Kreimer, Sara I Pai, Carole Fakhry, Joseph Monsonego, Silvia Franceschi

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Epidemiology, prevention and early detection of cervical cancer].Der Onkologe : Organ der Deutschen Krebsgesellschaft e.V · 2016
    Article
  7. Human papillomavirus and gastrointestinal cancer: A review.World journal of gastroenterology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 5 countries.

Julia M L BrothertonNational HPV Vaccination Program Register, VCS Registries, East Melbourne, Vic, Australia.
Mark JitModelling and Economics Unit, Public Health England, London, United Kingdom.
Patti E GravittDepartment of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM.
Marc BrissonDépartement de Médecine Sociale et Préventive, Université Laval, Québec, QC, Canada.
Aimée R KreimerInfections & Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
Sara I PaiDepartment of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA.
Carole FakhryDepartment of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins Outpatient Center, Baltimore, MD.
Joseph MonsonegoInstitut du Col, 174 Rue de Courcelles, Paris, 75017, France.
Silvia FranceschiInternational Agency for Research on Cancer, 69372 Lyon cedex 08, France.
Centre International de Recherche sur le Cancer · FRDivision of Cancer Epidemiology and GeneticsInstitut de France · FRJohns Hopkins University · USMassachusetts General Hospital · USMyer Foundation · AUPublic Health England · GBUniversité Laval · CAUniversity of New Mexico · US

Funding

Immune Checkpoints and HPV-associated Head and Neck CancersR01DE025340 · NIDCR · MASSACHUSETTS GENERAL HOSPITAL · PI PAI, SARA ISABEL · 2015 to 2017
$1.3M
NIDCR NIH HHS R01 DE025340World Health Organization 001
6 · The paper itself

Abstract

This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.

Indexed as

EuropeFemaleHead and Neck NeoplasmsHumansIncidenceMaleMass ScreeningNeoplasmsOutcome Assessment, Health CarePapillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsVaccinationPapillomavirus Vaccinescervical cancerHPVoropharyngeal cancervaccine

Identifiers

PMID26916230
PMCPMC7388730
OpenAlexW2283592640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.